JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
RPRX Financials - Royalty Pharma Income & Cash Flow | Ledgeburg
RPRX - Royalty Pharma PLC
USD | NASDAQ | Healthcare
Summary
Summary RPRX Stock
Financials
Financials RPRX Stock
Loading...
Loading...
Income Statement
Income Statement RPRX Stock
Balance Sheet
Balance Sheet RPRX Stock
Cash Flow Statement
Cash Flow Statement RPRX Stock
Loading...
Loading...
Home
Stocks
Royalty Pharma PLC (RPRX)
Financials
Financials of RPRX
Loading...
Loading...
Loading...
Loading...
Revenue
$2.378193B
Operating Income
$1.559518B
Net Income
$1.324192B
Share Count (Basic)
429.801M
Operating Cash Flow
$2.489823B
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$618.696M
Total Debt
$8.950917B
Annual
Quarterly
Revenue $USD
0
500M
1B
1.5B
2B
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
200M
400M
600M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
0
500M
1B
1.5B
Annual
Quarterly
Margins
Gross
Operating
Net
0%
20%
40%
60%
80%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
100M
200M
300M
400M
500M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
20%
40%
60%
80%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26